comprehensive -WSS

comprehensive

author：Wikipedia 2025-09-27 21:27:50 - browse：44

Eli Lilly headquarters in Indianapolis – pharmaceutical coverage from STAT — Darron Cummings/AP

The blockbuster weight loss and diabetes drug sold by Eli Lilly also appears to improve fatty liver disease, according to early clinical trial data the pharmaceutical company released Tuesday.

Eli Lilly reported during its fourth-quarter earnings call that tirzepatide, which is sold commercially as Mounjaro or Zepbound, succeeded in a Phase 2 test as a treatment for the liver disease MASH. Around 74% of adults in the trial taking the drug were free of MASH after 52 weeks, compared to approximately 13% of the placebo group.

MASH, formerly known as NASH, is a liver disease characterized by excess fat and inflammation. The chronic inflammation can also lead to liver scarring, or fibrosis.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Psychedelics group wrestles with new pharma identity
Next article： Former Pear Therapeutics executives start new VC firm

WSS

Trans patients at the end of life deserve respect and dignity

Study: Spinal cord stimulation helps patients with paralysis walk again

Information blocking fines are now fair game in health care

Why the drug industry's warnings on the IRA's impact fall short

Republicans love RFK Jr. What's that tell us about health in 2024?

Senate bill would ban some hospital facility fees

explore

comprehensive

knowledge

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

The unintended consequences of overturning Roe v. Wade

Moonlake's readout produced a cash windfall. Risks remain

Why the drug industry's warnings on the IRA's impact fall short

Novavax promises a turnaround & Lilly roils the obesity market

Listen: Vivek Ramaswamy's star turn & leaky drug data

Sports medicine is finally prioritizing gender equality

Eli Lilly CEO gives to Mike Pence presidential super PAC

In Memoriam: Notable people who died in 2023

White House Covid adviser calls on docs to combat misinformation

knowledge

Trans patients at the end of life deserve respect and dignity

FDA advisory panel to debate high blood pressure devices

How the messy conversation about Dolly changed bioethics

Wegovy improves function in certain heart failure patients

How the drug

PBMs are inflating the cost of generic drugs. They must be reined in

focus

knowledge

entertainment

knowledge